77
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological Features and Prognosis of Primary Mediastinal Malignant Germ Cell Tumors: A Retrospective Single-Institution Analysis

ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 8527-8534 | Published online: 13 Nov 2021

References

  • Rosti G, Secondino S, Necchi A, Fornarini G, Pedrazzoli P. Primary mediastinal germ cell tumors. Semin Oncol. 2019;46(2):107–111. doi:10.1053/j.seminoncol.2019.04.00131076171
  • van Leeuwen MT, Gurney H, Turner JJ, et al. Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982–2011. Cancer Epidemiol. 2016;43:15–21. doi:10.1016/j.canep.2016.05.00627235952
  • Adra N, Althouse SK, Liu H, et al. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014. Ann Oncol. 2016;27(5):875–879. doi:10.1093/annonc/mdw04526861605
  • Roden AC. Mediastinal germ cell tumors. In: Nogales FF, Jimenez RE, editors. Pathology and Biology of Human Germ Cell Tumors. Berlin, Heidelberg: Springer Berlin Heidelberg; 2017:327–364.
  • Stram AR, Kesler KA. Mediastinal germ cell tumors: updates in diagnosis and management. Surg Oncol Clin N Am. 2020;29(4):571–579. doi:10.1016/j.soc.2020.06.00532883459
  • Liu Y, Wang Z, Peng ZM, Yu Y. Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients. Diagn Pathol. 2014;9:33. doi:10.1186/1746-1596-9-3324552239
  • Marcus A, Narula N, Kamel MK, et al. Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions. Ann Diagn Pathol. 2019;39:69–73. doi:10.1016/j.anndiagpath.2019.02.01130797131
  • Dechaphunkul A, Sakdejayont S, Sathitruangsak C, et al. Clinical characteristics and treatment outcomes of patients with primary mediastinal germ cell tumors: 10-years’ experience at a single institution with a bleomycin-containing regimen. Oncol Res Treat. 2016;39(11):688–694. doi:10.1159/00045225927855414
  • Grabski DF, Pappo AS, Krasin MJ, Davidoff AM, Rao BN, Fernandez-Pineda I. Long-term outcomes of pediatric and adolescent mediastinal germ cell tumors: a single pediatric oncology institutional experience. Pediatr Surg Int. 2017;33(2):235–244. doi:10.1007/s00383-016-4020-027838767
  • Shamash J, Mee M, Sarker SJ, et al. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy. BJU Int. 2020;125(6):843–852. doi:10.1111/bju.1494731688976
  • Adra N, Abonour R, Althouse SK, Albany C, Hanna NH, Einhorn LH. High-dose chemotherapy and autologous peripheral-blood stem-cell transplantation for relapsed metastatic germ cell tumors: the Indiana University experience. J Clin Oncol. 2017;35(10):1096–1102. doi:10.1200/JCO.2016.69.539527870561
  • Kuwano H, Tsuchiya T, Murayama T, et al. Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors. Surg Today. 2014;44(3):499–504. doi:10.1007/s00595-013-0562-023553421
  • Necchi A, Bratslavsky G, Chung J, et al. Genomic features for therapeutic insights of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors and comparison with gonadal counterpart. Oncologist. 2019;24(4):e142–e145. doi:10.1634/theoncologist.2018-043030659078
  • Zschabitz S, Lasitschka F, Hadaschik B, et al. Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation. Eur J Cancer. 2017;76:1–7. doi:10.1016/j.ejca.2017.01.03328262583
  • International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol. 1997;15(2):594–603. doi:10.1200/JCO.1997.15.2.5949053482
  • Kollmannsberger C, Nichols C, Meisner C, Mayer F, Kanz L, Bokemeyer C. Identification of prognostic subgroups among patients with metastatic ‘IGCCCG poor-prognosis’ germ-cell cancer: an explorative analysis using cart modeling. Ann Oncol. 2000;11(9):1115–1120. doi:10.1023/A:100833322993611061604
  • Fedyanin M, Tryakin A, Mosyakova Y, et al. Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors. J Cancer Res Clin Oncol. 2014;140(2):311–318. doi:10.1007/s00432-013-1567-124337455
  • Wang J, Bi N, Wang X, et al. Role of radiotherapy in treating patients with primary malignant mediastinal non-seminomatous germ cell tumor: a 21-year experience at a single institution. Thorac Cancer. 2015;6(4):399–406. doi:10.1111/1759-7714.1219026273393
  • Alcarraz CE, Morante Z, Mejia G, et al. Clinicopathological features and management of patients with primary malignant mediastinal germ cell tumor: 10 year’s experience in Peruvian patients. J Clin Oncol. 2016;34(15_suppl):e13088–e13088. doi:10.1200/JCO.2016.34.15_suppl.e13088